Cambridge, MA, United States of America

Bianka Prinz

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bianka Prinz. Retrieved from https://idiyas.com/inventor/bianka-prinz-hpsphtvq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bianka Prinz: Innovator in Antibody Development

Introduction

Bianka Prinz is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of biotechnology. Her work primarily focuses on the development of antibodies that target specific proteins involved in various diseases.

Latest Patents

Bianka Prinz holds a patent for "Anti-CD19 antibodies and uses thereof." This patent describes antibodies, fragments thereof, and fusion proteins that specifically bind to CD19. These innovations are crucial for the treatment and diagnosis of various B-cell disorders, including B-cell malignancies and autoimmune diseases.

Career Highlights

Bianka Prinz is associated with Millennium Pharmaceuticals Limited, where she has been instrumental in advancing research in antibody therapies. Her expertise in this area has led to the development of novel therapeutic strategies that have the potential to improve patient outcomes.

Collaborations

Bianka has collaborated with esteemed colleagues such as Daniel Tavares and James Geoghegan, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Bianka Prinz's work in antibody development exemplifies the impact of innovative research in biotechnology. Her contributions are paving the way for new treatments for B-cell disorders, showcasing the importance of scientific advancement in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…